Related Experiment Videos
[Reaction times during citicoline treatment]
1Università degli Studi dell'Insubria, Patologia Medica, Ospedale di Circolo, Varese, Italia.
La Clinica Terapeutica
|October 29, 2002
Summary
Citicoline treatment significantly improved cognitive and behavioral functions in patients with cerebral involution. Two treatment cycles yielded better results with no observed side effects, enhancing brain health.
Area of Science:
- Neurology
- Pharmacology
Context:
- Investigating treatments for pathological cerebral involution of atrophic origin.
- Assessing the efficacy of Citicoline in a clinical setting.
Purpose:
- To evaluate the therapeutic effects of Citicoline on cognitive and behavioral capacities in patients with cerebral involution.
- To determine the optimal treatment duration and dosage for Citicoline.
Summary:
- Citicoline (1000 mg/day) was administered parenterally for 4 weeks to 40 patients. A subset received a second 4-week cycle after a 1-week washout.
- Significant improvements in reaction times, cognitive functions, and behavioral capacities were observed, as measured by the Clifton test and Green Relatives Stress Scale.
- Patients receiving two cycles of Citicoline demonstrated superior outcomes compared to those receiving a single cycle.
Impact:
- Citicoline shows promise as a safe and effective therapeutic agent for improving neurological function in patients with cerebral involution.
- The findings suggest that prolonged or repeated Citicoline administration may enhance treatment efficacy.
- This study provides evidence for the potential benefits of Citicoline in managing age-related cognitive decline and related behavioral changes.